Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

A Randomized, Open-label Study to Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

The pharmacokinetics (PK) and safety of oral DWP14012 tablet A will be evaluated and compared with those of DWP14012 tablet B in healthy subjects.

Inclusion Criteria:

• Healthy adults >=19years and <=45 years of age
• BMI >=17.5 kg/m2 and <30.5kg/m2, and body weight >= 55kg for male and >= 45kg for femlae
• subjects with no abnormal symptoms or findings based on physical examinations
• subjects determined eligible based on the results of lab tests
• subjects who agree to participate

Exclusion Criteria:

• Subjects with medical history that can not be participated

• Subjects with results of lab tests performed at screening which meet any of the following :

  • ALT or AST > 1.5 times the upper limit of normal
  • Diagnosis of Helicobacter pylori (H. pylori) positive result

• subject who is allergic to IP

• subject with history of serious alcohol or drug abuse within 1 year prior to screening.